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In Brief
Zhou et al. find that during viral infection, liver-resident NK (LrNK) cells inhibit the function of hepatic T cells via PD-1-PD-L1 interactions. Their findings reveal a role for LrNK cells in the regulation of T cell immunity and provide insight into the mechanisms of immune tolerance in the liver.
INTRODUCTION
Natural killer (NK) cells are important innate effectors, serving as a first line of defense against pathogens via direct cytotoxicity and the production of various cytokines (Vivier et al., 2008) . NK cells are also endowed with immune-regulatory functions through interactions with T cells, B cells, and dendritic cells (DCs), thus contributing to the shaping of the adaptive immune responses (Lam and Lanier, 2017; Schuster et al., 2016; Zhang et al., 2006) . NK cells can promote the differentiation of Th1 cells by secreting interferon-g (IFN-g) (Laouar et al., 2005; Martín-Fontecha et al., 2004) , and they can induce maturation of DCs and enhance their co-stimulatory roles (Adam et al., 2005; Gerosa et al., 2002; Mocikat et al., 2003) . NK cells also exert negative regulatory roles on T cell responses through direct and indirect mechanisms. NK cells can secrete interleukin-10 (IL-10) to inhibit
CD4
+ and CD8 + T cell responses (Deniz et al., 2008; Lee et al., 2009; Mehrotra et al., 1998) or directly kill CD4 + and CD8 + T cells (Cerboni et al., 2007; Rabinovich et al., 2003; Waggoner et al., 2011) . In addition, NK cells can eliminate DCs and thereby negatively regulate T cell responses (Cook and Whitmire, 2013) . NK cells are now considered a heterogeneous population with phenotypically and functionally distinct subsets Spits et al., 2016) . However, the respective roles of the different NK cell subsets remain undefined. Recently, we and others identified a unique subset of NK cells enriched in the murine liver, which we described as CD49a +
CD49b
À liver-resident NK (LrNK) cells (Peng et al., 2013; Sojka et al., 2014) . LrNK cells and conventional NK (cNK) cells exhibit significant differences in terms of phenotype, gene expression profile, and roles in contact hypersensitivity (Peng et al., 2013; Peng and Tian, 2017; Tang et al., 2016; Weizman et al., 2017) . Moreover, compared with cNK cells, LrNK cells require different transcription factors and progenitor origins for their development (Constantinides et al., 2014; Klose et al., 2014; Mackay et al., 2016; Zhang et al., 2016) . Therefore, LrNK cells represent a distinct cell lineage in the innate lymphoid cell (ILC) family and are also referred to as liver ILC1s to distinguish them from cNK cells. Although knowledge of this NK cell population is increasing, there are still many questions concerning the specific functional properties of the cells (Peng and Sun, 2017; Peng et al., 2016) . LrNK cells rapidly produce IFN-g at sites of primary viral infection and thereby limit early murine cytomegalovirus (MCMV) replication (Weizman et al., 2017) . However, it remains unknown whether, and to what extent, LrNK cells contribute to subsequent adaptive immune responses during viral infections.
Immune responses in the liver are generally associated with the induction of tolerance (Crispe, 2009 ). Administration of antigens via the portal vein can efficiently induce antigen-specific tolerance (Limmer et al., 2000) , and allogeneic liver transplants that are incompatible with major histocompatibility complex (MHC) are readily accepted without the need for immunosuppression (Cunningham et al., 2013; Tiegs and Lohse, 2010) . Hepatitis viruses, such as hepatitis B virus (HBV) and hepatitis C virus (HCV), can exploit the immunosuppressive liver microenvironment to establish life-long viral persistence (Protzer et al., 2012) . The tolerogenic microenvironment of the liver is associated with impaired T cell responses (Crispe, 2009; Tiegs and Lohse, 2010) . However, the precise cellular and molecular mechanisms underlying impaired T cell responses in hepatic tolerance induction are not fully understood.
Here, we found that LrNK cells negatively regulated the antiviral responses of hepatic T cells during acute and chronic viral infections and that this process was dependent on interaction between programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1). In contrast, cNK cells promoted antiviral T cell responses. Our findings reveal distinct functions for LrNK cells and provide insight into the complex immune regulatory mechanisms that underlie local tolerance and immunity.
RESULTS

LrNK Cells Exhibit a Negative Regulatory Feature
In accordance with previous research (Tang et al., 2016 ; Weizman et al., 2017), CD49a + CD49b À LrNK cells from wild-type (WT) mice at steady state highly expressed T-bet, CD200R, and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) but lacked eomesodermin (Eomes) expression ( Figure 1A ). In contrast, CD49a À CD49b + cNK cells were Eomes positive with nearly undetectable expression of CD200R and TRAIL ( Figure 1A ). To gain deeper insight into the functional roles of LrNK cells in immune responses, we compared the genome-wide transcriptional profiles of LrNK and liver cNK cells by using our previously published dataset (GEO: GSE43339) (Peng et al., 2013) . Genes involved in negative regulation of the immune response were enriched in LrNK cells compared with cNK cells ( Figure 1B ). LrNK cells were characterized by high expression of negative regulatory genes encoding LAG3 (Lag3), programmed cell death 1 ligand 2 (PD-L2; Pdcd1lg2), TRAIL (Tnfsf10), PD-L1 (Cd274), and CD39 (Entpd1). In contrast, cNK cells preferentially expressed cytotoxic effect genes encoding granzyme (B and C) Genome-wide transcriptional profiles of LrNK and liver cNK cells from a published dataset (GEO: GSE43339) (Peng et al., 2013) . (B) Raw data were normalized by robust multiarray averaging (RMA, R package), and differences in gene expression were analyzed for screening for the genes with a fold change > 1.5 between LrNK and liver cNK cells. Gene Ontology (GO) term enrichment of the differentially expressed genes was analyzed with the Database for Annotation, Visualization, and Integrated Discovery (DAVID). GO terms with p < 0.05 related to immune responses are shown. (C) Heatmap of the expression of selected genes that are associated with immune regulation and cytotoxicity in LrNK and liver cNK cells. (D) Flow-cytometry analysis of the indicated markers on LrNK and cNK cells in the livers of normal WT B6 mice.
(E) Statistical percentages of cells that express the indicated markers are shown. Data represent at least three independent experiments with three to nine mice per group (mean ± SEM; ns, not significant; **p < 0.01, ***p < 0.001, ****p < 0.0001). A (Gzma), CD107a (Lamp1), perforin (Prf1), and granzyme K (Gzmk) ( Figure 1C ).
To confirm this trend, we used flow cytometry to assess the expression of molecules related to negative regulatory function on LrNK cells from WT mice at steady state. Consistent with the gene expression data, LrNK cells preferentially expressed TRAIL and PD-L1 ( Figures 1A, 1D , and 1E), which can inhibit T cell responses via interaction with DR5 and PD-1 (Dong et al., 2004; Peppa et al., 2013; Schuster et al., 2014) .
Moreover, compared with cNK cells, LrNK cells had higher expression of CD39, CD73, and LAG3 ( Figures 1D and 1E) , which are associated with immunosuppressive functions of regulatory T cells (Bauché et al., 2018; Deaglio et al., 2007; Huang et al., 2004) . Although transcripts of PD-L2 and inducible co-stimulator (ICOS) ligand (ICOSL) were enriched in LrNK cells, flowcytometry analysis showed undetectable surface expression ( Figures 1C-1E ). Collectively, these differences in genetic and molecular expression profiles between LrNK and cNK cells raise the possibility that LrNK cells are involved in suppressing adaptive immune responses.
LrNK Cells Might Proliferate Locally during Viral Infection
To explore whether LrNK cells are involved in shaping adaptive immunity, we used a mouse model of lymphocytic choriomeningitis virus (LCMV) infection, in which NK cells are unable to directly control LCMV replication (Bukowski et al., 1983; Welsh et al., 1991) . Upon LCMV infection, NK cells accumulate dramatically in the liver (Liang et al., 2015; McIntyre and Welsh, 1986) . However, the dynamic composition of NK cell subsets during this process is unknown. During acute (Armstrong) and chronic (Clone13) LCMV infection, we observed that the numbers of LrNK and cNK cells increased within the first week after infection and then gradually decreased (Figures 2A and 2H ). To investigate whether the accumulation of NK cells in the liver was due to proliferation, we analyzed 5-bromo-2 0 -deoxyuridine (BrdU) incorporation and Ki67 staining by LrNK and cNK cells. At day 7 after LCMV infection, BrdU incorporation and Ki67 expression were increased in both NK cell subsets . Moreover, LrNK cells proliferated more vigorously than cNK cells . These results suggest that LrNK and cNK cells actively proliferate in response to viral infection.
LrNK cells represent a phenotypically stable lineage during homeostasis and MCMV infection (Peng et al., 2013; Tang et al., 2016; Weizman et al., 2017 Figure S1 ), and they maintained a stable phenotype, as evidenced by the stable expression of CD49a and T-bet and lack of CD49b and Eomes ( Figures 2O and 2P ). In contrast, cNK cells exhibited increased CD49a expression after infection ( Figures  2O and 2P ), consistent with previous findings regarding the phenotypic plasticity of cNK cells in tumor-and MCMV-induced inflammatory microenvironments (Cortez et al., 2017; Gao et al., 2017; Weizman et al., 2017 
To provide more space for donor-derived T cells, we irradiated the Rag1 (F) Viral titers in the livers from the recipient mice in (A) were analyzed at PI day 7.
(legend continued on next page)
Thus, these data indicate that LrNK cells can inhibit antiviral T cell responses.
We then analyzed T cell responses in other organs of mice that received T cells and were infected with LCMV Armstrong (Figure 3A) , and we found no difference in the number of antigenspecific T cells or viral titers in the spleens and lungs between Rag1
Tbx21
À/À and control recipients ( Figures S3D-S3G ).
Altogether, with the lack of changes in splenic T cell responses and viral titers after LrNK cell transfer , these results suggest that LrNK-cell-mediated inhibition of antiviral T cell responses is restricted to the liver without affecting other organs.
To explore whether the above conclusions also apply to other virus-induced acute infections, we then utilized a mouse model of acute adenovirus infection, in which bulk NK cells promote T cell responses (Liu et al., 2000) but in which LrNK cell function has not previously been studied. After adoptive transfer of T cells into Rag1 À/À Tbx21 À/À mice that were then infected with adenovirus, more CD4 + and CD8 + T cells were present in the livers of the Rag1
showed higher IFN-g and TNF-a expression, than in the livers of control mice at day 7 after infection ( Figures S4A-S4D ). Consistent with this finding, Rag1
a lower viral load in the liver and a higher ALT concentration than the control mice ( Figures S4E and S4F) . Notably, this process was reversed by adoptive transfer of T cells along with LrNK cells into the Rag1
Furthermore, in line with the observations during LCMV Armstrong infection, adoptive transfer of LrNK cells into WT mice, which were then infected with adenovirus, also inhibited T cell antiviral immunity, decreased lymphocyte infiltration, increased the viral burden in the liver, and reduced the serum ALT concentration, whereas cNK cells caused the reverse phenomena ( Figures S4G-S4M ).
In accordance with previous reports showing that T-bet regulates the terminal maturation of cNK cells (Gordon et al., 2012; Soderquest et al., 2011; Townsend et al., 2004) , we also found that there was a dramatic reduction in the most mature CD11b 
LrNK Cells Inhibit Hepatic T Cell Antiviral Responses during Chronic Viral Infection
To investigate whether LrNK cells exert similar roles during chronic viral infection, we used a murine model of chronic infection involving LCMV Clone13 (Lang et al., 2012; Waggoner et al., 2011) . Similar to the findings observed in acute viral infections, compared with control mice, Rag1
received an adoptive T cell transfer and underwent infection with LCMV Clone13 exhibited a higher number of antigen-specific T cells and enhanced cytokine secretion by T cells in the liver (Figures 4A-4F ). Additionally, a lower viral titer, increased lymphocyte infiltration in the liver, and a higher serum ALT concentration were also detected in Rag1
suggesting that LrNK cells restrain T cell responses during chronic viral infection.
To further verify the negative regulatory role of LrNK cells during chronic viral infection, we evaluated T cell function in WT mice that received an LrNK or a cNK cell transfer followed by challenge with LCMV Clone13 ( Figure 4J ). LrNK cells effectively reduced the number of antigen-specific T cells, leading to a higher viral burden in the liver and a lower serum ALT concentration, whereas cNK cells still played an opposing role ( Figures 4K-4P Figures 5A, 5B , 5E, 5F, 5I, and 5J). Furthermore, high expression of PD-1, the receptor for (legend continued on next page) PD-L1, was observed on hepatic CD4 + and CD8 + T cells after viral infection, whereas DR5, the receptor for TRAIL, was not expressed by hepatic T cells ( Figures 5C, 5D , 5G, 5H, 5K, and 5L). We also examined the expression of two other immunosuppressive molecules, CD39 and CD73, which are important for Treg cell functionality, involving the conversion of ATP to adenosine (Deaglio et al., 2007; Gu et al., 2017) . LrNK cells maintained high expression of CD39 but decreased CD73 expression after LCMV Armstrong infection ( Figure S5 ), suggesting that CD39 and CD73 might not be involved in LrNK-cell-mediated regulation of T cells. Thus, these findings raise the possibility that LrNK cells interact with T cells via PD-L1-PD-1 to exert suppressive functions.
LrNK Cells Regulate T Cell Functions via PD-L1 Checkpoint Control
To explore whether PD-L1 is responsible for LrNK-cell-mediated suppression of antiviral T cell responses, we pre-incubated LrNK cells with neutralizing anti-PD-L1 antibodies (Abs) before adoptive transfer into LCMV-Armstrong-or Clone13-infected mice ( Figures 6A and S7A) . Ex vivo blockade of PD-L1 on LrNK cells prior to adoptive transfer did not affect the in vivo trafficking of LrNK cells after virus challenge ( Figure S6 ). After PD-L1 blockade, the number and proliferation of hepatic virus-specific T cells were higher than and the cytokine-producing abilities of the hepatic T cells were superior to those in the mice receiving LrNK cells without PD-L1 blockade ( Figures 6B-6G, 6J-6N , and S7B-S7M), implying that PD-L1 expression on LrNK cells negatively regulates hepatic T cell responses. Moreover, blockade of PD-L1 on LrNK cells led to an increased serum ALT concentration ( Figures 6I and S7O ) and a decreased viral load ( Figures 6H and  S7N) . To confirm the role of the PD-1-PD-L1 axis in LrNK-cellmediated regulation, we transferred T cells from Pdcd1 À/À (PD-
control mice, which were analyzed 14 days after LCMV Clone13 infection ( Figure S7P ). We found no differences regarding the number of hepatic antigen-specific T cells, viral titer, or ALT concentration between Rag1 À/À Tbx21 À/À and control mice ( Figures 7A and 7B) . Furthermore, the inhibitory role of LrNK cells was mediated by cell-cell contact and not by soluble factors, as evidenced by Transwell assays (Figures 7C and 7D ). This indicates that LrNK cells directly regulate T cell responses. Additionally, blockade of PD-L1 in the co-culture system restored T cell proliferation in the presence of LrNK cells, whereas blockade of TRAIL did not ( Figure 7E ). Therefore, these data collectively demonstrate that LrNK cells directly suppress T cell responses via the engagement of the PD-L1 checkpoint.
DISCUSSION
NK cells are crucial effectors of innate immunity and also act as modulators of adaptive immune responses (Crome et al., 2013; Schuster et al., 2016; Waggoner et al., 2011) . However, previous studies focused on bulk NK cells, which are now known to be a mixture of cNK cells, tissue-resident NK cells, and mucosal ILC1s (Artis and Spits, 2015) . The respective roles of different NK cell subsets in regulating adaptive immune responses are unclear. In this study, we investigated the contribution of liver NK cell subsets to adaptive immunity in the context of viral infections and defined distinct functions of LrNK and cNK cells. The liver is an attractive target site for pathogens because of its immune tolerogenic properties (Gao, 2016; Protzer et al., 2012) . The liver contains a high frequency of NK cells in comparison with other tissues, and LrNK cells account for nearly half of the hepatic bulk NK cells (Peng et al., 2013) . Expression of the inhibitory receptor NKG2A on NK cells contributes to HBV persistence . LrNK cells preferentially express NKG2A in comparison with cNK cells, and the absence of NKG2A results in enhanced activation of DCs and expansion of virus-specific CD8 + T cells during adenovirus infection (Krueger et al., 2017) . Whether this effect is mediated by LrNK cells directly is unclear. By using Rag1 There is accumulating evidence of bulk NK-cell-mediated impairment of virus-specific T cell immunity in LCMV infection models (Lang et al., 2012; Waggoner et al., 2011; Waggoner et al., 2010) . In contrast, during acute adenovirus infection, NK cells release IFN-g to facilitate antiviral T cells responses (Krueger et al., 2017; Liu et al., 2000) . Possible explanations for this disparity in NK cell function include differences between studies in the viral species or dose, timing of NK cell depletion, and mouse strain. Virus-specific CD8 + T cells display enhanced
IFN-g production in Nfil3
À/À mice after infection with the strain LCMV WE (Lang et al., 2012) . However, in addition to the loss of cNK cells, the number of LrNK cells, ILC2s, and ILC3s are simultaneously reduced in Nfil3 À/À mice (Geiger et al., 2014; Seillet et al., 2014; Tang et al., 2016) . ILC2s and ILC3s are also able to regulate T cell responses (Hepworth et al., 2013; Schwartz et al., 2017) . Therefore, whether the enhanced T cell responses in Nfil3 À/À mice are caused by a lack of cNK cells or a lack of other cell types is unclear from this previous study (Lang et al., 2012) . By using Ncr1
Cre/+ Eomes fl/fl mice that are specifically deficient in cNK cells, we found lower virus-specific T cell responses in these mice compared with littermate Ncr1 +/+ Eomes fl/fl control mice, suggesting a role for cNK cells in the promotion of T cell responses during viral infection. Although the mechanism was not explored deeply in our study, previous research suggests that NK cells can be recruited to lymph nodes, where they secrete IFN-g to induce Th1 responses (Martín-Fontecha et al., 2004) . Considering the strong migratory capacity of cNK cells, this might provide an explanation for the enhanced antiviral T cell responses induced by cNK cells.
PD-1 blockade can lead to improved immune responses to LCMV infection (Ahn et al., 2018; Barber et al., 2006; Mueller et al., 2010; Penaloza-MacMaster et al., 2014) . The PD-1-PD-L1 pathway curbs inflammation in the liver (Dong et al., 2004) and inhibits antiviral immunity during adenovirus infection (Iwai et al., 2003) . However, the cellular pathways involved in these processes have not been clearly demonstrated. Here, we found that LrNK cells had high expressions of immunosuppressive molecules at steady state. In particular, the immune checkpoint inhibitor PD-L1 was constitutively expressed on LrNK cells and further increased during viral infections, and its receptor PD-1 was concurrently increased on T cells. Consistent with previous evidence showing impaired T cell responses induced by the PD-1-PD-L1 axis (Dong et al., 2004; Schildberg et al., 2016) , treatment of LrNK cells with Abs blocking PD-L1 effectively restored antiviral T cell functions in vivo and enhanced T cell proliferation in vitro. These findings suggest that LrNK cells negatively regulate T cell responses via a PD-L1-dependent mechanism.
In chronic MCMV infection, CD4 + T cells accumulate in the salivary glands and show elevated expression of the TRAIL receptor, rendering them vulnerable to TRAIL-mediated lysis (Schuster et al., 2014) . This lysis process is thought to be mediated by TRAIL expressed on salivary gland NK cells. In addition, in human chronic HBV infection, NK cells negatively regulate antiviral T cell responses in a TRAIL-dependent manner (Peppa et al., 2013) . Notably, LrNK cells also expressed high amounts of TRAIL at steady state. However, after infection with LCMV or adenovirus for 7 days, TRAIL expression on LrNK cells was decreased, and the expression of its receptor DR5 on hepatic T cells remained low. These findings are further supported by the observation that blocking TRAIL had no effect on T cell proliferation during co-culture of T and LrNK cells, suggesting that TRAIL is dispensable for LrNK-cell-mediated T cell suppression.
Human NK cells are also thought to have a negative regulatory function. CD56 bright CD27
+ decidual NK cells function as key regulatory cells to maintain maternal-fetal tolerance by secreting IFN-g to dampen Th17 cells (Fu et al., 2013) . CD56 + CD3 À cells in tumor-infiltrating lymphocyte cultures can suppress T cell expansion via NKp46 (Crome et al., 2017) . Unique NK cell subsets resembling murine LrNK cells are also present in humans. Human CXCR6 + or CD49e À NK cells, which are specifically enriched in the liver but rare in the circulation, are considered human LrNK cells (Aw Yeang et al., 2017; Cuff et al., 2016; Stegmann et al., 2016) . However, these LrNK cells selectively express Eomes rather than T-bet (Aw Yeang et al., 2017; Harmon et al., 2016) , in contrast to T-bet + Eomes À mouse LrNK cells (Sojka et al., 2014) . The functional differences of cytokine production and degranulation capacity between human LrNK cells and cNK cells are still controversial (Aw Yeang et al., 2017; Harmon et al., 2016) , and the primary physiological function of human LrNK cells remains to be fully determined. PD-1 blockade can enhance HBV-specific CD8 + T cell proliferation and inflammatory cytokine production (Zhang et al., 2008) , suggesting that a negative signaling pathway is in operation in human HBV infection. PD-1 is also implicated in impairment of virus-specific T cells from HCV-infected patients (Raziorrouh et al., 2011; Urbani et al., 2008) . Thus, together with our findings regarding murine LrNK cells, these results show that it will be of interest to investigate whether human LrNK cells can also negatively regulate T cell responses via the PD-1-PD-L1 axis during hepatotropic virus infection. Data represent three to five independent experiments with three to five mice per group (mean ± SEM; ns, not significant; **p < 0.01, ***p < 0.001, ****p < 0.0001). See also Figure S5 .
(legend on next page)
However, because the immune microenvironment is complex, it still cannot be concluded that LrNK cells inhibit T cells in all settings. In different circumstances, NK cells might perform distinct roles. Given that LrNK cells can efficiently produce multiple cytokines, such as IFN-g, TNF-a, and granulocytemacrophage colony-stimulating factor (GM-CSF) (Sojka et al., 2014; Tang et al., 2016) , it is possible that LrNK cells might promote Th1 cell polarization under certain conditions. Thus, more work is needed to comprehensively evaluate the functions of LrNK cells in other conditions (such as tumors, autoimmune diseases, and transplant rejection) and in different phases of diseases.
Altogether, these results reveal a PD-L1-dependent immunosuppressive function of LrNK cells during viral infection and differential roles of LrNK and cNK cells in the regulation of hepatic T cell responses. Considering the differential compositions of NK cell subsets in different tissues, the results of this study have profound implications for our understanding of the specific features of local immunity.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice WT C57BL/6 (WT B6) mice were purchased from the Shanghai Experimental Animal Center (Shanghai, China). Tbx21 À/À (T-bet-deficient) mice and CD45.1 + B6.SJL mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA). Rag1 À/À mice were purchased from the Model Animal Research Center (Nanjing, China), and they were crossed with Tbx21 À/À mice to obtain Rag1
À/À (PD-1-deficient) mice were purchased from Beijing Biocytogen Co., Ltd. (Beijing, China).
Ncr1(NKp46)
Cre/+ Eomes fl/fl mice were provided by Zhongjun Dong (Tsing Hua University, Beijing, China). 6-12-week-old male and female mice were used. Mice were sex-and age-matched for individual experiments. All mice were housed in a specific-pathogen-free facility with unrestricted access to food and water in compliance with the guidelines for the use of experimental animals at the University of Science and Technology of China.
METHOD DETAILS
Viruses and infection details A replication-deficient adenovirus was purchased from 5 + MMI (Beijing, China). Mice were infected with 2 3 10 9 infectious units (ifu) of adenovirus by intravenous (i.v.) injection. The lymphocytic choriomeningitis virus (LCMV) Armstrong and Clone13 strains were generous gifts from Rafi Ahmed (Emory University, GA, USA). Mice were infected intraperitoneally (i.p.) with 2 3 10 5 plaque forming units (PFU) of LCMV Armstrong or i.v. with 2 3 10 6 PFU of LCMV Clone13.
Cell isolation
Isolation of liver mononuclear cells (MNC) and splenocytes was performed as previously described (Wang et al., 2006) . Briefly, the livers were removed and pressed through a 200-gauge mesh, and liver MNCs were collected following 40%-70% percoll density gradient centrifugation. The spleens were also removed and pressed through a 200-gauge mesh. Splenic single-cell leukocyte suspensions were prepared by lysing the erythrocytes with red cell lysis buffer. Isolation of lung lymphocytes was conducted as described previously . Briefly, the lung was cut into pieces and incubated at 37 C for 60 min in Roswell Park Memorial Institute (RPMI) 1640 medium (Hyclone, South Logan, UT, USA) with 0.1% collagenase I and 5% fetal calf serum (FCS). The supernatant was collected and the lymphocytes were purified by Percoll gradient centrifugation.
Antibody staining and flow cytometry Monoclonal antibodies (mAbs) against CD4 (RM4-5), CD8 (53-6.7), CD49a (Ha31/8), CD49b (CD49b), CD107a (1D4B), LAG3 (C9B7W), PD-L1 (MIH5), PD-L2 (TY25), and IFN-g (XMG1.2) were purchased from BD Biosciences (San Jose, CA, USA). Abs against CD39 (24DMS2), CD73 (TY/11.8), DR5 (MD5-1), Eomes (Dan11mag), Granzyme B (16G6), Ki67 (SolA15), TRAIL (N2B2), and Perforin (eBioOMAK-D) were purchased from eBioscience (San Diego, CA, USA). Abs against CD3ε (145-2C11), CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70), CD19 (1D3/CD19), CD27 (LG.3A10), CD45 (30-F11), CD45.1 (A20), CD45.2 (104), CD200R (OX-110), ICOSL (HK5.3), IFN-g (XMG1.2), IL-2 (JES7-5H4), NK1.1 (PK136), NKp46 (29A1.4), PD-1 (29F.1A12), T-bet (4B10), and TNF-a (MP6-XT22) were purchased from BioLegend (San Diego, CA, USA). The anti-LCMV gp33 tetramer was purchased from Medical & Biological Laboratories (Nagoya, Japan). The anti-LCMV gp66 tetramer was provided by the National Institutes of Health Tetramer Core Facility (Emory University, GA, USA). The isolated cells were incubated with rat serum to block Fc receptors followed by staining with fluorescently labeled mAbs against surface molecules. For intracellular cytokine staining, cells were stimulated with 30 ng/mL phorbol myristate acetate (PMA; Sigma-Aldrich, St. Louis, MO, USA) and 1 mg/mL ionomycin (Sigma-Aldrich) for 4 h, and 2 mg/mL monensin (Sigma-Aldrich) was added at the beginning of stimulation. After surface staining, cells were fixed, permeabilized (using a FoxP3/Transcription Factor Buffer Set; eBioscience), and then stained with mAbs against the intracellular molecules. All data were collected using a flow cytometer (LSR II and LSRFortessa X-20; BD Biosciences) and analyzed with FlowJo software (Tree Star, Ashland, OR, USA). ). The purity of the sorted cell populations was > 95%, as verified by post-sort flow cytometry. For in vivo study, purified cells were transferred into sublethally irradiated (5 Gy given 1 day before adoptive transfer) recipient mice, which were then infected with LCMV or adenovirus and assessed at 7 or 14 days post infection.
Cell sorting and transfer
